Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Myelodysplastic Syndromes (MDS) Clinical Trials

A listing of Myelodysplastic Syndromes (MDS) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 Last 

Colorado

Denver Colorado 80218

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Florida

Tampa Florida 33602

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Maryland

Baltimore Maryland 21231

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Massachusetts

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Missouri

Kansas City Missouri 64128

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

New York

Bronx New York 10461

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Lake Success New York 11020

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

New York New York 10032

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

North Carolina

Winston-Salem North Carolina 27157

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

North Dakota

Ohio

Cleveland Ohio 44195

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Tennessee

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Texas

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Tyler Texas 75702

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Virginia

Norfolk Virginia 23502

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Washington

Yakima Washington 98902

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

West Virginia

West Virginia University - Clinical Trials Research Unit
Morgantown West Virginia 26506

E2905: Randomized Phase III Trial Comparing the frequency of Major Erythroid Response to Treatment with Lenolidomide Alone and in Combination with Epoetin Alfa in Subjects with Low or Intermediate 1 Risk MDS and Symptomatic Anemia

Argentina

Ciudad Autonoma de Buenos Aires 1114

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Ciudad Autonoma de Buenos Aires 1425

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Santa Fe S3000ADL

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Australia

Adelaide South Australia 5000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Clayton Victoria 3168

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

East Melbourne Victoria 3002

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Kogarah New South Wales 2217

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Belgium

Brugge 8000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Leuven 3000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Turnhout 2300

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Czech Republic

Brno 625 00

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Ostrava 708 52

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Praha 10 100 34

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Praha 2 128 08

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Denmark

Aarhus 8000 C

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

France

Bobigny 93009

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Le Mans 72000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Lille 59037

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Nanes 44000

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Rouen 13273

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

View More ▼

Rouen Cedex 1 76038

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Toulouse 31059

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Germany

Dresden Sachsen 01307

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Frankfurt 60590

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Muenchen Bayern 81675

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Münster 48129

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Greece

Patra 26500

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Thessaloniki 54642

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Hong Kong

Chai Wan

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Hong Kong

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Hungary

Debrecen 4012

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

First 1 2 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.